tiprankstipranks
Trending News
More News >
Carlsmed, Inc. (CARL)
NASDAQ:CARL
US Market

Carlsmed, Inc. (CARL) Financial Statements

Compare
51 Followers

Carlsmed, Inc. Financial Overview

Carlsmed, Inc.'s market cap is currently $342.25M. The company's EPS TTM is $-0.4; its P/E ratio is -12.87; Carlsmed, Inc. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 24Dec 23
Income Statement
Total Revenue$ 27.16M-$ 13.78M
Gross Profit$ 20.05M-$ 9.90M
Operating Income$ -24.12M-$ -18.59M
EBITDA$ -22.79M-$ -18.12M
Net Income$ -24.26M-$ -18.90M
Balance Sheet
Cash & Short-Term Investments$ 40.13M$ ―$ 7.22M
Total Assets$ 51.82M-$ 14.02M
Total Debt$ 17.18M-$ 11.39M
Net Debt$ -22.95M-$ 4.17M
Total Liabilities$ 122.45M-$ 60.15M
Stockholders' Equity$ -70.63M$ ―$ -46.13M
Cash Flow
Free Cash Flow$ -25.65M-$ -17.61M
Operating Cash Flow$ -25.47M-$ -17.48M
Investing Cash Flow$ -180.00K-$ -135.00K
Financing Cash Flow$ 58.50M-$ 3.18M
Currency in USD

Carlsmed, Inc. Earnings and Revenue History

Carlsmed, Inc. Debt to Assets

Carlsmed, Inc. Cash Flow

Carlsmed, Inc. Forecast EPS vs Actual EPS